DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2)-Reference-Cited by-同舟云学术

DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2)

Published:2020-04 Issue:4 Volume:82 Page:838-845
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Bertucci Vince,Solish Nowell,Kaufman-Janette Joely,Yoelin Steve,Shamban Ava,Schlessinger Joel,Snyder Daniel,Gallagher Conor,Liu Yan,Shears Gill,Rubio Roman G.

Funder

Revance Therapeutics, Inc.

Revance Therapeutics, Inc

Publisher

Elsevier BV

Subject

Dermatology

Reference17 articles.

1. Social implications of hyperfunctional facial lines;Finn;Dermatol Surg,2003

2. A double-blind, randomized, placebo-controlled health-outcomes survey of the effect of botulinum toxin type A injections on quality of life and self-esteem;Dayan;Dermatol Surg,2010

3. Evolution of facial aesthetic treatment over five or more years: a retrospective cross-sectional analysis of continuous onabotulinumtoxinA treatment;Carruthers;Dermatol Surg,2015

4. Injectable daxibotulinumtoxinA for the treatment of glabellar lines: a phase 2, randomized, dose-ranging, double-blind, multicenter comparison with onabotulinumtoxinA and placebo;Carruthers;Dermatol Surg,2017

5. Injectable daxibotulinumtoxinA in cervical dystonia: a phase 2 dose-escalation multicenter study;Jankovic;Mov Disord Clin Pract,2018

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Benefits of DaxibotulinumtoxinA for Injection: Beyond Glabellar Line Effacement?;Dermatologic Surgery;2024-09

2. DaxibotulinumtoxinA for injection to treat moderate or severe glabellar lines: a randomized, multicenter, Phase III, double-blind, placebo-controlled trial in China;Journal of Plastic, Reconstructive & Aesthetic Surgery;2024-09

3. Male Rejuvenation;Facial Plastic Surgery Clinics of North America;2024-08

4. Safety and Duration of Effect of 40-Unit PrabotulinumtoxinA-xvfs for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients: A Phase II, Multicenter, Randomized, Double-Blind, Active-Controlled Trial;Aesthetic Surgery Journal;2024-03-20

5. Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia;Neurology;2024-02-27